ATC/DDD

ATC/DDD index H01CA

You are here: Home > ATC/DDD > H > H01 > H01C

- ATC/DDD
Anatomical therapeutic chemical (ATC) classification system
- H
SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
- H01
PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES
- H01C
HYPOTHALAMIC HORMONES

H01CA

Gonadotropin-releasing hormones

ATC/DDD code H01CA for Gonadotropin-releasing hormones

Buserelin, goserelin, histrelin, leuprorelin, and triptorelin are classified in L02AE Gonadotropin releasing hormone analogues.

Gonadorelin used as diagnostic agent is classified in V04CM.

The DDD of nafarelin is based on the treatment of endometriosis.

No other DDDs have been assigned, due to the highly variable dosages used.

H01CA01
Gonadorelin
H01CA02
Nafarelin
H01CA03
Histrelin
ICD-10
ATC
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10

ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO).

It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.

ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

DDD

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO).

It is used to standardize the comparison of drug usage between different drugs or between different health care environments.

Home Contact Us